Latest news
RGNX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law ReviewThe National Law Review · Sat, 08 Aug 2026 12:57:21 GMTREGENXBIO (NASDAQ:RGNX) Rating Increased to Hold at Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 06:05:03 GMTA Quick Look at Today's Ratings for Regenxbio(RGNX.US), With a Forecast Between $12 to $45 - MoomooMoomoo · Fri, 07 Aug 2026 19:06:22 GMTRegenxbio Seen on Track for Duchenne Approval as Data Strengthens, RBC Says - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 17:37:18 GMTREGENXBIO Inc. (RGNX) stock price, news, quote and history - Yahoo Finance UKYahoo Finance UK · Fri, 07 Aug 2026 15:55:55 GMTBarclays Reiterates "Equal Weight" Rating for REGENXBIO (NASDAQ:RGNX) - MarketBeatMarketBeat · Fri, 07 Aug 2026 12:30:22 GMTREGENXBIO Inc. (RGNX) Stock Price, News, Quote & History - Yahoo! Finance CanadaYahoo! Finance Canada · Fri, 07 Aug 2026 12:21:03 GMTSarepta Hits Fresh Hurdle As Court Revives Patent Lawsuit With Regenxbio Over Muscular Disorder Therapy - StocktwitsStocktwits · Fri, 07 Aug 2026 12:06:44 GMT